Skip to main content

Animations

MJFF Publications

6091 - 6100 of 6324 Results
Title
Year
  • Year
  • 2016
  • 2020
  • 2024
  • 2017
  • 2023
  • 2024
  • 2020
  • 2020
  • 2021
  • 2025
  • Summary Details
    OPEN
    Title: LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-016-0234-2
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-020-04897-6
    Citation Count: 42
  • Summary Details
    OPEN
    Title: OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106070
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00216
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Genome‐Wide Analysis of Structural Variants in Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26608
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.27158
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Lack of evidence for association of UQCRC1 with Parkinson's disease in Europeans
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.030
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.aaz9165
    Citation Count: 53
  • Summary Details
    OPEN
    Title: echolocatoR: an automated end-to-end statistical and functional genomic fine-mapping pipeline
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btab658
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Retro-Walking and Cholinergic Network Correlates in Parkinson’s Disease
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.14802/jmd.25109
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.